Department of Pharmacology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan.
Department of Immunology, Kitasato University School of Medicine, Kanagawa, Japan.
Cardiovasc Res. 2023 May 22;119(5):1218-1233. doi: 10.1093/cvr/cvac137.
Microsomal prostaglandin E synthase-1 (mPGES-1)/prostaglandin E2 (PGE2) induces angiogenesis through the prostaglandin E2 receptor (EP1-4). Among immune cells, regulatory T cells (Tregs), which inhibit immune responses, have been implicated in angiogenesis, and PGE2 is known to modulate the function and differentiation of Tregs. We hypothesized that mPGES-1/PGE2-EP signalling could contribute to recovery from ischaemic conditions by promoting the accumulation of Tregs.
Wild-type (WT), mPGES-1-deficient (mPges-1-/-), and EP4 receptor-deficient (Ep4-/-) male mice, 6-8 weeks old, were used. Hindlimb ischaemia was induced by femoral artery ligation. Recovery from ischaemia was suppressed in mPges-1-/- mice and compared with WT mice. The number of accumulated forkhead box protein P3 (FoxP3)+ cells in ischaemic muscle tissue was decreased in mPges-1-/- mice compared with that in WT mice. Expression levels of transforming growth factor-β (TGF-β) and stromal cell derived factor-1 (SDF-1) in ischaemic tissue were also suppressed in mPges-1-/- mice. The number of accumulated FoxP3+ cells and blood flow recovery were suppressed when Tregs were depleted by injecting antibody against folate receptor 4 in WT mice but not in mPges-1-/- mice. Recovery from ischaemia was significantly suppressed in Ep4-/- mice compared with that in WT mice. Furthermore, mRNA levels of Foxp3 and Tgf-β were suppressed in Ep4-/- mice. Moreover, the number of accumulated FoxP3+ cells in ischaemic tissue was diminished in Ep4-/- mice compared with that in Ep4+/+ mice.
These findings suggested that mPGES-1/PGE2 induced neovascularization from ischaemia via EP4 by promoting the accumulation of Tregs. Highly selective EP4 agonists could be useful for the treatment of peripheral artery disease.
微粒体前列腺素 E 合酶-1(mPGES-1)/前列腺素 E2(PGE2)通过前列腺素 E2 受体(EP1-4)诱导血管生成。在免疫细胞中,调节性 T 细胞(Tregs)抑制免疫反应,与血管生成有关,已知 PGE2 调节 Tregs 的功能和分化。我们假设 mPGES-1/PGE2-EP 信号可能通过促进 Tregs 的积累来促进缺血条件的恢复。
使用 6-8 周龄野生型(WT)、mPGES-1 缺陷型(mPges-1-/-)和 EP4 受体缺陷型(Ep4-/-)雄性小鼠。通过股动脉结扎诱导后肢缺血。与 WT 小鼠相比,mPges-1-/- 小鼠的缺血恢复受到抑制。与 WT 小鼠相比,缺血肌肉组织中积累的叉头框蛋白 P3(FoxP3)+细胞数量减少。mPges-1-/- 小鼠缺血组织中转化生长因子-β(TGF-β)和基质细胞衍生因子-1(SDF-1)的表达水平也受到抑制。在 WT 小鼠中注射叶酸受体 4 抗体耗尽 Tregs 时,积累的 FoxP3+细胞数量和血流恢复受到抑制,但在 mPges-1-/- 小鼠中则没有。与 WT 小鼠相比,Ep4-/- 小鼠的缺血恢复明显受到抑制。此外,Ep4-/- 小鼠的 Foxp3 和 Tgf-β mRNA 水平受到抑制。此外,与 Ep4+/+ 小鼠相比,缺血组织中积累的 FoxP3+细胞数量减少。
这些发现表明,mPGES-1/PGE2 通过促进 Tregs 的积累,通过 EP4 诱导缺血引起的新血管生成。高选择性 EP4 激动剂可用于治疗外周动脉疾病。